Alembic Pharmaceuticals Q2 Results
- BSE: 533573
- NSE: APLLTD
- ISIN: INE901L01018
- Sector: Biotechnology & Drugs
BSE
1,030.30
53.85 (5.51%)
53.85 (5.51%)Volume21.86 K
Updated: Mon 14 Jul, 2025 | 15:40:01
NSE
1,030.4053.80 (5.51%)
53.80 (5.51%)Volume6.62 L
Updated: Mon 14 Jul, 2025 | 15:44:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Alembic Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 1,466.36 | 1,393.94 | 5.20% |
| Depreciation/ Amortization | 70.51 | 69.04 | 2.13% |
| Operating Income | 181.62 | 167.79 | 8.24% |
| Net Income | 153.40 | 134.37 | 14.16% |
| Other Operating Expenses Total | 588.13 | 551.04 | 6.73% |
| Net Income Before Taxes | 180.42 | 157.03 | 14.90% |
| Total Revenue | 1,647.98 | 1,561.73 | 5.52% |
| Selling/ General/ Admin Expenses Total | 391.47 | 379.77 | 3.08% |
| Diluted Normalized EPS | 7.24 | 6.84 | 5.78% |